State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in DexCom Inc common stock as of the event date of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported beneficial ownership of 18,917,265 shares of DexCom Inc common stock, representing 5% of the class.
  • Shared voting power: The filing disclosed shared voting power over 12,153,366 shares, with sole voting power reported as 0.
  • Shared dispositive power: State Street reported shared dispositive power over 18,896,988 shares, with sole dispositive power reported as 0.
  • Filing entity type: State Street Corporation identified itself as a parent holding company or control person (type HC) organized in Massachusetts.
  • Subsidiaries involved: Ten investment adviser subsidiaries are listed in the filing, including SSGA Funds Management, Inc. and multiple State Street Global Advisors entities across several countries.
  • Ordinary course certification: The filing certifies the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

State Street's Schedule 13G Filing on DexCom Ownership

State Street Corporation, headquartered at One Congress Street, Suite 1, Boston, MA 02114, filed a Schedule 13G disclosing its beneficial ownership in DexCom Inc (CUSIP 252131107), whose principal executive offices are located at 6340 Sequence Drive, San Diego, California 92121. The triggering event date for the filing is September 30, 2026, and the statement was signed by Alok Maheshwary, Senior Vice President, on November 9, 2026.

According to the filing, State Street's aggregate beneficial ownership stands at 18,917,265 shares, equal to 5% of DexCom's outstanding common stock. The company reported zero sole voting power and zero sole dispositive power, with shared voting authority over 12,153,366 shares and shared dispositive authority over 18,896,988 shares. The filing notes that Item 5 (Ownership of 5 Percent or Less of a Class) is listed as "Not Applicable," consistent with the reported 5% threshold figure.

The filing identifies ten subsidiaries through which the position is held, all classified as investment advisers (IA). These include SSGA Funds Management, Inc., State Street Global Advisors Trust Company, and regional State Street Global Advisors entities operating in Japan, Asia, Europe, Australia, Singapore, and Saudi Arabia, as well as State Street Global Advisors, Ltd. and State Street Global Advisors, LTD. State Street Corporation did not identify any other person known to have the right to receive dividends or sale proceeds from the reported shares, designating Item 6 as "Not Applicable."

What Was Disclosed

State Street Corporation disclosed a 5% beneficial ownership stake in DexCom Inc common stock as of September 30, 2026, held through ten investment adviser subsidiaries, with shared but no sole voting or dispositive power over the reported shares.